Antiplatelet agent vs control
Fatal or nonfatal myocardial infarction · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
Antiplatelet agents probably leads to lower fatal or nonfatal myocardial infarction compared with control (moderate certainty).
1 finding from 1 review
- RR 0.88 [0.79, 0.99]18 studies · 15289 participantsModerate